Characteristics of Peanut Allergy Diagnosis in a US Health Care Claims Database (2011-2017)

Todd A Mahr1, Jay A Lieberman2, Tmirah Haselkorn3

  • 1Division of Allergy, Asthma, and Immunology, Gundersen Health System, La Crosse, Wis.

Insights

Peanut allergy incidence and prevalence in US children are rising, with over a million cases by 2017. Severe reactions and healthcare use are high, indicating a significant public health burden.

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health Epidemiology
  • Real-World Evidence Studies

Background:

  • Peanut allergy is the most prevalent childhood food allergy.
  • Limited real-world data exists on the burden of pediatric peanut allergy.

Purpose of the Study:

  • To estimate the annual incidence and prevalence of peanut allergy in US children aged 4-17.
  • To assess severe reaction rates and healthcare utilization for peanut allergy.

Main Methods:

  • Utilized US healthcare claims data (2011-2017) for children aged 4-17.
  • Identified peanut allergy cases via diagnostic codes and severe reaction indicators.
  • Calculated incidence and prevalence, adjusting for data limitations; analyzed severe reactions and healthcare visits.

Main Results:

  • Annual incidence rose from 1.7% to 5.2% (2001-2017).
  • Prevalence reached 1.25 million (2.2%) in 2017 for ages 4-17.
  • Over half experienced severe reactions; 37.9% from accidental exposure; 1 in 5 had emergency visits.

Conclusions:

  • Peanut allergy incidence and prevalence in the US appear to be increasing.
  • High rates of severe reactions and healthcare utilization underscore the considerable burden of peanut allergy.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
30.2K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Cross-reactivity00:42

Cross-reactivity

Overview
32.1K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K